Clinical trials
Breast Neoplasms trials in Spain
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
837 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 7 |
| 2002 | 8 |
| 2003 | 12 |
| 2004 | 19 |
| 2005 | 16 |
| 2006 | 22 |
| 2007 | 30 |
| 2008 | 22 |
| 2009 | 30 |
| 2010 | 19 |
| 2011 | 19 |
| 2012 | 43 |
| 2013 | 43 |
| 2014 | 38 |
| 2015 | 32 |
| 2016 | 34 |
| 2017 | 34 |
| 2018 | 30 |
| 2019 | 40 |
| 2020 | 54 |
| 2021 | 50 |
| 2022 | 42 |
| 2023 | 55 |
| 2024 | 49 |
| 2025 | 52 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 448 |
| Recruiting | 118 |
| Active, not recruiting | 107 |
| Terminated | 87 |
| Unknown status | 57 |
| Not yet recruiting | 10 |
| Enrolling by invitation | 4 |
| Approved for marketing | 3 |
| Withdrawn | 2 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 77 |
| Novartis Pharmaceuticals | 61 |
| AstraZeneca | 43 |
| Spanish Breast Cancer Research Group | 43 |
| Eli Lilly and Company | 34 |
| Pfizer | 30 |
| SOLTI Breast Cancer Research Group | 29 |
| MedSIR | 27 |
| Genentech, Inc. | 17 |
| GlaxoSmithKline | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Neoplasms | 837 |
| Neoplasm Metastasis | 78 |
| Neoplasms | 66 |
| Ovarian Neoplasms | 37 |
| Carcinoma, Non-Small-Cell Lung | 33 |
| Triple Negative Breast Neoplasms | 33 |
| Colorectal Neoplasms | 27 |
| Endometrial Neoplasms | 23 |
| Lung Neoplasms | 19 |
| Stomach Neoplasms | 19 |
Trials
Showing 1 to 25 of 837. Each trial links to its page on Pharma Observatory.
737 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.